NANOBIOTIX (EPA:NANO) | Finanzwire

Basculer en Français

10591	Companies
224581	Keywords
153310	Articles
118794	Press releases

Home
Companies
NANOBIOTIX

PRESS RELEASE

published on 09/30/2025 at 00:30, 8 months 18 days ago

NANOBIOTIX Announces Updated Phase 1 Results Continuing to Support JNJ-1900 (NBTXR3) Plus Anti-PD-1 as a Potential New 1L or 2L+ Option in Anti-PD-1 Naïve or Resistant R/M-HNSCC
Nanobiotix announces updated phase 1 results supporting JNJ-1900 plus anti-PD-1 as a new option in R/M-HNSCC. Promising local and systemic responses presented at ASTRO 2025

NANOBIOTIX Anti-PD-1 JNJ-1900 R/M-HNSCC ASTRO 2025
BRIEF

published on 09/17/2025 at 22:20, 9 months ago

New Positive Results for NANOBIOTIX in Phase 1 Melanoma Study

Efficiency Melanoma NANOBIOTIX Phase 1 JNJ-1900
PRESS RELEASE

published on 09/17/2025 at 22:15, 9 months ago

NANOBIOTIX Announces New Results From a Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in Combination With Immune Checkpoint Inhibitors as a 2L+ Therapy for Patients With Primary Cutaneous Melanoma Resistant to Anti-PD-1
Nanobiotix announces new results from a Phase 1 study evaluating JNJ-1900 (NBTXR3) in combination with immune checkpoint inhibitors as a 2L+ therapy for patients with primary cutaneous melanoma resistant to anti-PD-1. Favorable safety profile and early efficacy signals observed

Melanoma NANOBIOTIX Immune Checkpoint Inhibitors Phase 1 Study JNJ-1900
BRIEF

published on 09/12/2025 at 19:05, 9 months 5 days ago

Nanobiotix Announces Voting Rights and Share Capital Details

Voting Rights Shares Euronext Nasdaq NANOBIOTIX
PRESS RELEASE

published on 09/12/2025 at 19:00, 9 months 5 days ago

Voting Rights and Shares Capital of the Company
Nanobiotix releases voting rights and shares capital details. The company is listed on Euronext Paris and Nasdaq, pioneering biotechnology for treatment advancements

Euronext Paris Voting Rights Nasdaq Shares Capital NANOBIOTIX
BRIEF

published on 09/02/2025 at 22:20, 9 months 15 days ago

Nanobiotix at the HC Wainwright Global Investment Conference

Investors Biotechnology Conference Therapeutics NANOBIOTIX
PRESS RELEASE

published on 09/02/2025 at 22:15, 9 months 15 days ago

Nanobiotix to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
Nanobiotix to participate in H.C. Wainwright 27th Annual Global Investment Conference with a fireside chat featuring company management. Nanoparticle-based treatments for cancer and major diseases

Fireside Chat NANOBIOTIX H.C. Wainwright Conference Late-stage Biotechnology Nanoparticle-based Treatments
BRIEF

published on 08/27/2025 at 08:05, 9 months 21 days ago

Nanobiotix Announces Voting Rights and Shares Capital Update

Euronext Paris Voting Rights Biotechnology Shares Capital NANOBIOTIX
PRESS RELEASE

published on 08/27/2025 at 08:00, 9 months 21 days ago

Voting Rights and Shares Capital of the Company
Nanobiotix announces voting rights and shares capital details as per French Commercial Code regulations. The late-stage clinical biotech company focuses on disruptive therapies in oncology, bioavailability, and CNS disorders

Voting Rights French Commercial Code Biotechnology Shares Capital NANOBIOTIX
BRIEF

published on 08/11/2025 at 11:34, 10 months 6 days ago

Threshold Crossings by The Goldman Sachs Group, Inc. at Nanobiotix

Actions Financial Market Goldman Sachs Crossing Thresholds NANOBIOTIX

Accesswire

Published on 06/18/2026 at 00:00, 3 hours 4 minutes ago

LIR Life Sciences Completes Comparative Animal Study Showing Successful Protamine-Enhanced Permeation Transport of Both Semaglutide and Tirzepatide
Published on 06/17/2026 at 23:30, 3 hours 34 minutes ago

Polaris Renewable Energy Announces Postponement of Annual Meeting of Shareholders
Published on 06/17/2026 at 22:50, 4 hours 14 minutes ago

International Battery Metals Ltd. Reports Fourth Quarter and Full Year Fiscal 2026 Financial Results
Published on 06/17/2026 at 22:30, 4 hours 34 minutes ago

Innodata Appoints Jayant Chauhan as Chief Financial Officer
Published on 06/17/2026 at 16:55, 10 hours 9 minutes ago

Snipp Interactive Named a Representative Vendor in the Gartner(R) 2026 Market Guide for Loyalty Program Vendors

View all ACCESSWIRE

EQS Group

Published on 06/18/2026 at 02:45, 19 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Update on APAC matter
Published on 06/17/2026 at 21:40, 5 hours 24 minutes ago

Tinnitus Quest Builds Momentum with Oxford Research Study, New Funding Call, and Second Tinnitus Hackathon
Published on 06/17/2026 at 19:10, 7 hours 54 minutes ago

Africa Finance Corporation and Leading Italian Institutions Sign Strategic Cooperation Agreements at AFC-Italy Forum to Mobilise Capital and Accelerate Industrial Development Across Africa
Published on 06/17/2026 at 18:40, 8 hours 24 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 06/17/2026 at 18:36, 8 hours 28 minutes ago

BILENDI: Bilendi announces that Euroland Corporate has initiated coverage of its shares

Les Echos

Published on 06/17/2026 at 17:40, 9 hours 24 minutes ago

Report on share repurchases from 10 to 16 June 2026
Published on 06/17/2026 at 08:45, 18 hours 19 minutes ago

Air Liquide is awarded its largest-ever contract in Spain to care for 90,000 patients living with respiratory conditions at home
Published on 06/16/2026 at 11:44, 1 day 15 hours ago

Guillemot Corporation S.A. | Weekly report share buyback from June 8 to June 12 2026
Published on 06/15/2026 at 23:00, 2 days 4 hours ago

BIOPHYTIS ANNOUNCES THE TEMPORARY SUSPENSION OF THE TRADING OF ITS SHARES
Published on 06/15/2026 at 18:57, 2 days 8 hours ago

Reporting on share buyback transactions carried out between June 8 and June 11, 2026

View all LES ECHOS COMFI WIRE